Metraipolis › archive › dc_da3f46e21501
Risk Factors Influencing Efficacy and Prognosis Evaluation of Neoadjuvant Systemic Therapy in Triple-Positive Breast Cancer — Europe PMC PMID:42099018
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42099018
- DOI
- 10.1002/kjm2.70228
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T15:14:44.589Z
- SHA-256 of the archived text
0339832ba48e1bb65d58a654a1477760f4e521a6f4875ede1c444424af4aeafd- Stable URL of this page
https://metraipolis.com/documento/dc_da3f46e21501
How to cite
Risk Factors Influencing Efficacy and Prognosis Evaluation of Neoadjuvant Systemic Therapy in Triple-Positive Breast Cancer — Europe PMC PMID:42099018 — Europe PMC (en), https://europepmc.org/article/MED/42099018 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_da3f46e21501 (Metraipolis archive dc_da3f46e21501, sha256 0339832ba48e1bb65d58a654a1477760f4e521a6f4875ede1c444424af4aeafd)
BibTeX
@misc{dcda3f46e21501,
title = {Risk Factors Influencing Efficacy and Prognosis Evaluation of Neoadjuvant Systemic Therapy in Triple-Positive Breast Cancer — Europe PMC PMID:42099018},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42099018},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_da3f46e21501; sha256 0339832ba48e1bb65d58a654a1477760f4e521a6f4875ede1c444424af4aeafd},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42099018. Agents can read the archived copy with the MCP tool read_document.